<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="137918">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01911481</url>
  </required_header>
  <id_info>
    <org_study_id>IDRI</org_study_id>
    <nct_id>NCT01911481</nct_id>
  </id_info>
  <brief_title>Maternal Oral Hydration and External Cephalic Version</brief_title>
  <official_title>Maternal Oral Hydration and External Cephalic Version: a Single Blind Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Milano Bicocca</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Milano Bicocca</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are carrying out a study of 164 pregnant women, with breech presentation
      at term who will undergo to external cephalic version. The investigators' goal is to know if
      oral maternal hydration can increase the successful of external cephalic version
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2011</start_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Caregiver)</study_design>
  <primary_outcome>
    <measure>Number of participants with external cephalic version successful after maternal oral hydration</measure>
    <time_frame>The primary outcome will be assessed by ultrasound examination,  5 minutes after  ending  of the external cephalic version</time_frame>
    <safety_issue>No</safety_issue>
    <description>The primary outcome of the study is to evaluate the successful rate  of external cephalic version, after oral intake of two litres of water</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>amniotic fluid volume</measure>
    <time_frame>1 hour after the end of oral maternal hydration (2 litres)</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will assess the amniotic fluid index at recruitment (Baseline). 1 hour after ending of oral intake (2 litres of water), we will revalue the amniotic fluid volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>type of birth</measure>
    <time_frame>at birth</time_frame>
    <safety_issue>No</safety_issue>
    <description>We will record if the woman will give birth by cesarean section or vaginal birth (spontaneous or operative)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>type of breech presentation</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>At recruitment we will assess the type of breech (frank breech, complete breech, footling or incomplete breech)</description>
  </other_outcome>
  <other_outcome>
    <measure>placental localisation</measure>
    <time_frame>baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>At recruitment we will assess the placental localisation (anterior, posterior, right lateral, left lateral or fundal)</description>
  </other_outcome>
  <other_outcome>
    <measure>foetal back position</measure>
    <time_frame>baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>At recruitment we will evaluate the position of fetal back (anterior, posterior, right or left lateral)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">164</enrollment>
  <condition>External Cephalic Version</condition>
  <condition>Maternal Oral Hydration</condition>
  <arm_group>
    <arm_group_label>hydration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>after recruitment the women in hydration group will be invited to drink 2 litres of water,in 2 hours</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>hydration</intervention_name>
    <arm_group_label>hydration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  single gestation

          -  breech presentation

          -  from 37 to 41,5 weeks

          -  without pregnancy complications

          -  fetus adequate for gestational age

          -  without fetal malformations

          -  intact membranes

          -  amniotic fluid index between 7 and 24 cm

          -  placenta properly inserted

        Exclusion Criteria:

          -  age less than 18 years

          -  maternal disease at risk of fluid overload (cardiac disease, renal impairment,
             moderate or severe preeclampsia or hypertension and diabetes)

          -  contraindications for vaginal birth

          -  vaginal blood loss

          -  uterine contractions
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonietta A Scian, MD</last_name>
    <role>Study Chair</role>
    <affiliation>San Gerardo Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Virna Franca VF Zobbi, PhD</last_name>
    <phone>+39 0392339841</phone>
    <email>virna.zobbi@unimib.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>San Gerardo Hospital</name>
      <address>
        <city>Monza</city>
        <state>Monza Brianza</state>
        <zip>20900</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virna Franca VF Zobbi, PhD</last_name>
      <phone>+39 0392339841</phone>
      <email>virna.zobbi@unimib.it</email>
    </contact>
    <investigator>
      <last_name>Antonietta A Scian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 26, 2013</lastchanged_date>
  <firstreceived_date>July 22, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Milano Bicocca</investigator_affiliation>
    <investigator_full_name>CARLO GAMBACORTI PASSERINI</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
